Medical use of icaritin
AssigneeLunan Pharmaceutical Group Corporation
InventorsGuimin Zhang, Jingchun Yao, Chenghong Sun, Bin Li, Sina Pan
Life of this patent
Estimating the term…
Abstract
The present disclosure provides use of icaritin in preparing a drug for preventing and treating a bleeding disorder and belongs to the field of medicine. The icaritin can relieve platelet dysfunction, shorten thromboplastin time, and promote blood coagulation, and can be used for preventing and treating the bleeding disorder, especially for treating hemorrhagic transformation after cerebral infarction, gastrointestinal bleeding caused by a thrombolytic or antithrombotic drug for cerebral infarction, or a bleeding complication of a thrombolytic or antithrombotic drug for myocardial infarction.
Claims20
A method of preventing or treating a bleeding disorder, comprising administering a prophylactically or therapeutically effective amount of icaritin to a subject in need of such treatment, wherein the bleeding disorder is a bleeding disorder caused by platelet dysfunction, a bleeding disorder caused by vessel wall abnormalities or a bleeding disorder caused by anticoagulation and fibrinolysis abnormalities;
- wherein, the bleeding disorder caused by the platelet dysfunction is hemorrhagic transformation after cerebral infarction, gastrointestinal bleeding caused by a thrombolytic or antithrombotic drug for cerebral infarction, or a bleeding complication of a thrombolytic or antithrombotic drug for myocardial infarction.
Dependencies are inferred from the claim text.